Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05723172
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2023-01-25
Brief Title:
40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimers Disease
Sponsor:
Che-Sheng Chu
Organization:
Kaohsiung Veterans General Hospital
Study Overview
Official Title:
40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimers Disease a Triple Blind Randomized Sham-controlled Trial
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Gamma brain activity is crucial for cognitive function and intra-brain communication Gamma frequency stimulation via transcranial alternating current stimulationtACS might alleviate memory deficits on both animal models of Alzheimers disease AD and clinical trial The study aims to assess the safety and efficacy of tACS on cognitive function and modulating neurophysiology in patients with AD
Detailed Description:
Gamma brain activity is crucial for cognitive function and intra-brain communication Gamma frequency stimulation via transcranial alternating current stimulationtACS might alleviate memory deficits on both animal models of Alzheimers disease AD and clinical trial The study aims to assess the safety and efficacy of tACS on cognitive function and modulating neurophysiology in patients with AD
40mins 10Hz-tACS for daily consecutive sessions will be given
40mins 10Hz-tACS for daily consecutive sessions will be given
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None